Evidence map›Paper›PMID 30555480›Full record

ReviewFrontiers in immunology2018

The Influence of Pentraxin 3 on the Ovarian Function and Its Impact on Fertility.

Antonella Camaioni, Francesca Gioia Klinger, Luisa Campagnolo, Antonietta Salustri

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Kidney disease and reproductive health.Nature reviews. Nephrology · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. The NovelBioinformatics and biology insights · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Insights into the Relationship between Pentraxin-3 and Cancer.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antonella CamaioniHistology and Embryology Section, Department of Biomedicine and Prevention, University of Rome "Tor Vergata," Rome, Italy.
Francesca Gioia KlingerHistology and Embryology Section, Department of Biomedicine and Prevention, University of Rome "Tor Vergata," Rome, Italy.
Luisa CampagnoloHistology and Embryology Section, Department of Biomedicine and Prevention, University of Rome "Tor Vergata," Rome, Italy.
Antonietta SalustriHistology and Embryology Section, Department of Biomedicine and Prevention, University of Rome "Tor Vergata," Rome, Italy.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follicular development is a highly coordinated process that in humans takes more than 6 months. Pituitary gonadotropins and a variety of locally produced growth factors and cytokines are involved in determining a precise sequence of changes in cell metabolism, proliferation, vascularization, and matrix remodeling in order to obtain a follicle with full ovulatory and steroidogenic capability. A low-grade inflammation can alter such processes leading to premature arrest of follicular growth and female reproductive failure. On the other hand, factors that are involved in inflammatory response as well as in innate immunity are physiologically upregulated in the follicle at the final stage of maturation and play an essential role in ovulation and fertilization. The generation of pentraxin 3 (PTX3) deficient mice provided the first evidence that this humoral pattern recognition molecule of the innate immunity has a non-redundant role in female fertility. The expression, localization, and molecular interactions of PTX3 in the periovulatory follicle have been extensively studied in the last 10 years. In this review, we summarize findings demonstrating that PTX3 is synthesized before ovulation by cells surrounding the oocyte and actively participates in the organization of the hyaluronan-rich provisional matrix required for successful fertilization. Data in humans tend to confirm these findings, indicating PTX3 as a biomarker of oocyte quality. Moreover, we discuss the emerging evidence that in humans altered PTX3 systemic levels, determined by genetic variations and/or low-grade chronic inflammation, can also impact the growth and development of the follicle and affect the incidence of ovarian disorders.

Indexed as

Immunity, InnateAnimalsC-Reactive ProteinExtracellular MatrixFemaleFertilityHumansOocytesOvarian DiseasesOvarian FolliclePentraxinsSerum Amyloid P-ComponentC-Reactive ProteinPentraxinsSerum Amyloid P-Componentcumulus matrixfertilityfollicle growthovarian disordersPCOSPTX3theca cells

Identifiers

PMID30555480
PMCPMC6283082
OpenAlexW2902976346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.